AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19059660 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 186
Study 19059660 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 186
Study 19059660 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg
Number of subjects: 186
Study 19059660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg
Number of subjects: 186
Study 19059660 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg
Number of subjects: 186
Study 19059660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study 18354390 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 9% CO2
Number of subjects: 64
Study 18354390 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 17.5% CO2
Number of subjects: 64
Study 18354390 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 35% CO2
Number of subjects: 64
Study 18354390 — intervention group
Group type: COMPARATOR
Intervention: Inhalation of 0% CO2 (control)
Number of subjects: 64
Study 16097710 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg vardenafil every other day for 7 weeks after the intervention
Number of subjects: 60
Study 16097710 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vardenafil)
Number of subjects: 60
Study 16097710 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group (vardenafil)
Number of subjects: 60
Study 12451366 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 units of BTX‐A
Number of subjects: 0
Study 12451366 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 units of BTX‐A
Number of subjects: 0
Study 12451366 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 units of BTX‐A
Number of subjects: 0
Study 12451366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10612642 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet drugs
Number of subjects: 1560
Study 10612642 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprostadil-alpha-cyclodextrine
Number of subjects: 1560
Study 10612642 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularisation
Number of subjects: 1560
Study 10612642 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior major vascular events
Number of subjects: 1560
Study 10612642 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes (cardiovascular risk factor)
Number of subjects: 1560
Study 10612642 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue loss
Number of subjects: 1560
Study 10612642 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle pressure (unmeasurable)
Number of subjects: 1560
Study 10612642 — intervention group
Group type: COMPARATOR
Intervention: Revascularisation (compared to surgery deemed unnecessary)
Number of subjects: 1560
Study 7500239 — intervention group
Group type: EXPERIMENTAL
Intervention: ePTFE interproximal membranes in combination with decalcified freeze‐dried bone (DFDBA)
Number of subjects: 11
Study 7500239 — intervention group
Group type: COMPARATOR
Intervention: ePTFE interproximal membranes alone (control)
Number of subjects: 11
Study 8257542 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycoprotein
Number of subjects: 0
Study 8257542 — intervention group
Group type: COMPARATOR
Intervention: Chicken
Number of subjects: 0
Study 2878134 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine 5 mg in 5 ml of water
Number of subjects: 15
Study 2878134 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine 150 micrograms in 5 ml of saline
Number of subjects: 15
Study 2878134 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural buprenorphine 0.3 mg in 5 ml of saline
Number of subjects: 15
Study 2878134 — intervention group
Group type: COMPARATOR
Intervention: No injection
Number of subjects: 15
Study 29326420 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 °C exposure
Number of subjects: 20
Study 29326420 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 °C exposure
Number of subjects: 20
Study 29326420 — intervention group
Group type: EXPERIMENTAL
Intervention: 27 °C exposure
Number of subjects: 20
Study 29326420 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature decrease
Number of subjects: 20
Study 29326420 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting irisin
Number of subjects: 20
Study 29326420 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial RQ at 20 °C
Number of subjects: 20
Study 29326420 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin to glucose ratios at 20 °C
Number of subjects: 20
Study 29326420 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature difference (27 °C vs 20 °C)
Number of subjects: 20
Study 27318524 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper alloy surfaces
Number of subjects: 515
Study 27318524 — intervention group
Group type: COMPARATOR
Intervention: Non-copper surfaces
Number of subjects: 515
Study 25823765 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead-free radiation-attenuating drape (n=50)
Number of subjects: 100
Study 25823765 — intervention group
Group type: COMPARATOR
Intervention: Sham drapes (n=50)
Number of subjects: 100
Study 23437807 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation for AVNRT
Number of subjects: 83
Study 23437807 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation for nonsustained AVNRT
Number of subjects: 83
Study 22051332 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous B-type natriuretic peptide (BNP)
Number of subjects: 58
Study 22051332 — intervention group
Group type: COMPARATOR
Intervention: Volume expansion (VE) with normal saline (0.25 ml/kg/min for 60 min)
Number of subjects: 58
Study 19194157 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (20 and 40 ng/ml)
Number of subjects: 55
Study 19194157 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.45 and 0.9 microg/ml)
Number of subjects: 55
Study 19194157 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.25 and 0.4 ng/ml)
Number of subjects: 55
Study 19194157 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental (1.5 and 3 microg/ml)
Number of subjects: 55
Study 19194157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 16357331 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg twice daily
Number of subjects: 770
Study 16357331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 770
Study 15070633 — intervention group
Group type: EXPERIMENTAL
Intervention: Three days of oral amoxicillin 31‐54 mg/kg/day in three divided doses
Number of subjects: 2188
Study 15070633 — intervention group
Group type: EXPERIMENTAL
Intervention: Five days of oral amoxicillin 31‐54 mg/kg/day in three divided doses
Number of subjects: 2188
Study 11295017 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic foam seat cushion
Number of subjects: 32
Study 11295017 — intervention group
Group type: COMPARATOR
Intervention: Pressure‐reducing seat cushion
Number of subjects: 32
Study 9651060 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional or digitally subtracted selective angiograms
Number of subjects: 1001
Study 9651060 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventionally and digitally subtracted aortic arch injection angiograms
Number of subjects: 1001
Study 9651060 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous digital subtraction angiograms
Number of subjects: 1001
Study 9651060 — intervention group
Group type: EXPERIMENTAL
Intervention: Good quality angiograms
Number of subjects: 1001
Study 9651060 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor quality angiograms
Number of subjects: 1001
Study 9651060 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of plaque surface morphology
Number of subjects: 1001
Study 9651060 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective angiograms with good quality visualization
Number of subjects: 1001
Study 8062314 — intervention group
Group type: EXPERIMENTAL
Intervention: carteolol (15 mg/d)
Number of subjects: 15
Study 8062314 — intervention group
Group type: COMPARATOR
Intervention: atenolol (50 mg/d)
Number of subjects: 15
Study 3190508 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhubarb pie
Number of subjects: 16
Study 3190508 — intervention group
Group type: EXPERIMENTAL
Intervention: Steamed rice
Number of subjects: 16
Study 3190508 — intervention group
Group type: COMPARATOR
Intervention: Citric acid (52, 156, and 260 mmol/l)
Number of subjects: 16
Study 28741894 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 126
Study 28741894 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 126
Study 26547101 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography and ultrasonography (intervention group)
Number of subjects: 72998
Study 26547101 — intervention group
Group type: COMPARATOR
Intervention: Mammography alone (control group)
Number of subjects: 72998
Study 24919603 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine with stepwise addition of up to three insulin glulisine injections (G + 3)
Number of subjects: 0
Study 24919603 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily premixed 70/30 insulin protamine-aspart/aspart (PM-2)
Number of subjects: 0
Study 24919603 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine with up to one insulin glulisine injection (G + 1)
Number of subjects: 0
Study 22889675 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 40
Study 22889675 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 40
Study 22889675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 20109213 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg PO once daily for 5 days, repeated every 8 weeks for a total of six courses
Number of subjects: 1149
Study 20109213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1149
Study 18524823 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA priming followed by Ad5 boosting
Number of subjects: 120
Study 18524823 — intervention group
Group type: COMPARATOR
Intervention: Homologous Ad5/Ad5 prime-boost regimen
Number of subjects: 120
Study 15904728 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil-midazolam
Number of subjects: 41
Study 15904728 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil-midazolam
Number of subjects: 41
Study 14728392 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic patient diary (ED)
Number of subjects: 0
Study 14728392 — intervention group
Group type: COMPARATOR
Intervention: Paper diary (PD)
Number of subjects: 0
Study 10103325 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention period (January 1998 - March 1998) with price information provided to physicians.
Number of subjects: 0
Study 10103325 — intervention group
Group type: COMPARATOR
Intervention: Washout period (April 1998) after intervention.
Number of subjects: 0
Study 10103325 — intervention group
Group type: COMPARATOR
Intervention: Control period (September 1997 - December 1997) without price information.
Number of subjects: 0
Study 2702680 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 668
Study 2702680 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG + DTIC
Number of subjects: 668
Study 410230 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% disodium cromoglycate (DSCG) nasal spray
Number of subjects: 24
Study 30617786 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated DOMS Group (RD Group)
Number of subjects: 23
Study 29653492 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Arts Education (VAE)
Number of subjects: 26
Study 29653492 — intervention group
Group type: COMPARATOR
Intervention: Control group (slide shows, discussions about art, and painting)
Number of subjects: 26
Study 28117536 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary prevention ICD
Number of subjects: 0
Study 28117536 — intervention group
Group type: COMPARATOR
Intervention: Implantable loop recorder (ILR)
Number of subjects: 0
Study 28117536 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life assessed by Minnesota Living with Heart Failure Questionnaire
Number of subjects: 0
Study 28117536 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure related hospitalizations
Number of subjects: 0
Study 28117536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-utility analysis
Number of subjects: 0
Study 24839145 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for overweight, Class I, and Class II obese women
Number of subjects: 958
Study 24839145 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 958
Study 24256551 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for 10-year patient survival after baseline developed through multivariate Cox regression analysis.
Number of subjects: 13868
Study 24256551 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of registration on the transplant waiting list as a predictor.
Number of subjects: 13868
Study 21225104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (10 mg/kg)
Number of subjects: 80
Study 21225104 — intervention group
Group type: COMPARATOR
Intervention: Dipyrone (15 mg/kg)
Number of subjects: 80
Study 20011884 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic instructions regarding surgery procedures and ventilatory exercises
Number of subjects: 51
Study 20011884 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physiotherapeutic instructions)
Number of subjects: 51
Study 17535290 — intervention group
Group type: EXPERIMENTAL
Intervention: ANALOGUE (optimized analogue therapy; lispro/glargine)
Number of subjects: 21
Study 17535290 — intervention group
Group type: EXPERIMENTAL
Intervention: CSII (continuous subcutaneous insulin infusion therapy; lispro)
Number of subjects: 21
Study 17535290 — intervention group
Group type: COMPARATOR
Intervention: EDUCATION (re-education with relaxation of blood glucose targets on existing conventional insulin regimen)
Number of subjects: 21
Study 15471655 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 134
Study 15471655 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 134
Study 15471655 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy only (not pre-treated with chemotherapy)
Number of subjects: 134
Study 11598580 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracanal corticosteroid-antibiotic compound
Number of subjects: 480
Study 11598580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study 9649455 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beclomethasone dipropionate (8 mg/day) plus prednisone (1 mg.kg‐1.day‐1)
Number of subjects: 60
Study 9649455 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules plus prednisone (1 mg.kg‐1.day‐1)
Number of subjects: 60
Study 7979170 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C intake of 20 mg/kg or more
Number of subjects: 0
Study 7979170 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C intake above 20 mg/kg/day
Number of subjects: 0
Study 7979170 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C intake of 8 mg/kg/day
Number of subjects: 0
Study 2898368 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (0.2 mg)
Number of subjects: 0
Study 2898368 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (2 x 0.1 mg)
Number of subjects: 0
Study 2898368 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (2 x 0.25 mg)
Number of subjects: 0
Study 2898368 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous theophylline (maximal mean plasma concentration 14.9 +/- 2.2 mg l-1) after placebo inhalation
Number of subjects: 0
Study 2898368 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of theophylline and fenoterol
Number of subjects: 0
Study 217218 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfinpyrazone
Number of subjects: 0
Study 217218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31232823 — intervention group
Group type: EXPERIMENTAL
Intervention: Flower petal training
Number of subjects: 16
Study 31232823 — intervention group
Group type: COMPARATOR
Intervention: Chicken leg femoral artery training
Number of subjects: 16
Study 27411333 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 2.0 ng/ml
Number of subjects: 34
Study 27411333 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 3.0 ng/ml
Number of subjects: 34
Study 27411333 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 4.0 ng/ml
Number of subjects: 34
Study 27411333 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious stimuli (laryngoscopy/intubation, tetanic, incision)
Number of subjects: 34
Study 25442112 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone (0.4 mg)
Number of subjects: 53
Study 25442112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 24045005 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based tailored intervention (alternating condition, n=132)
Number of subjects: 448
Study 24045005 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based tailored intervention (summative condition, n=181)
Number of subjects: 448
Study 24045005 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based tailored intervention (both conditions combined)
Number of subjects: 448
Study 24045005 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=135)
Number of subjects: 448
Study 24045005 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating condition
Number of subjects: 448
Study 22487920 — intervention group
Group type: EXPERIMENTAL
Intervention: Local EMLA cream preoperatively (Group I, N=15)
Number of subjects: 45
Study 22487920 — intervention group
Group type: COMPARATOR
Intervention: No preoperative preparation (Group II, N=15)
Number of subjects: 45
Study 22487920 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (Group III, N=15)
Number of subjects: 45
Study 20500126 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (80 mg, 3x/day for 6 days followed by a challenge dose of 250 mg)
Number of subjects: 165
Study 20500126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 17683327 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartz tungsten halogen curing light
Number of subjects: 70
Study 17683327 — intervention group
Group type: COMPARATOR
Intervention: Plasma arc curing light
Number of subjects: 70
Study 16219950 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of orbital irradiation and systemic steroids (SRT group)
Number of subjects: 16
Study 16219950 — intervention group
Group type: COMPARATOR
Intervention: Systemic steroids alone (ST group)
Number of subjects: 16
Study 12153596 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex) 6.5 mg/m2
Number of subjects: 19
Study 12153596 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone (Pred) 40 mg/m2
Number of subjects: 19
Study 10206611 — intervention group
Group type: EXPERIMENTAL
Intervention: Intersulcate line measurement method
Number of subjects: 36
Study 10206611 — intervention group
Group type: COMPARATOR
Intervention: Line of eburnation measurement method
Number of subjects: 36
Study 7628186 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg prednisone
Number of subjects: 13
Study 7628186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 2699147 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of five markers (CEA, SCC, TPA, CA 50, ferritin)
Number of subjects: 54
Study 2699147 — intervention group
Group type: EXPERIMENTAL
Intervention: SCC marker
Number of subjects: 54
Study 2699147 — intervention group
Group type: EXPERIMENTAL
Intervention: Five markers (CEA, SCC, TPA, CA 50, ferritin)
Number of subjects: 54
Study 2699147 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up on 21 randomized patients
Number of subjects: 54
Study 91778 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP (1-desamino-8-D-arginine vasopressin)
Number of subjects: 4
Study 30701435 — intervention group
Group type: EXPERIMENTAL
Intervention: SST with unstructured play
Number of subjects: 45
Study 30701435 — intervention group
Group type: EXPERIMENTAL
Intervention: SST with semi-structured play
Number of subjects: 45
Study 30701435 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 45
Study 27856020 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography-assisted lumbar puncture
Number of subjects: 128
Study 27856020 — intervention group
Group type: COMPARATOR
Intervention: Traditional lumbar puncture
Number of subjects: 128
Study 26551181 — intervention group
Group type: COMPARATOR
Intervention: Planned cesarean delivery
Number of subjects: 2603
Study 26551181 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned vaginal delivery
Number of subjects: 2603
Study 22760005 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte/monocyte apheresis (GMA)
Number of subjects: 235
Study 22760005 — intervention group
Group type: COMPARATOR
Intervention: Sham apheresis
Number of subjects: 235
Study 21204103 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 0
Study 21204103 — intervention group
Group type: COMPARATOR
Intervention: Infliximab
Number of subjects: 0
Study 19138505 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600mg o.d.
Number of subjects: 286
Study 19138505 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 500microg b.i.d.
Number of subjects: 286
Study 19138505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study 16962156 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cues
Number of subjects: 0
Study 16962156 — intervention group
Group type: COMPARATOR
Intervention: Single cues
Number of subjects: 0
Study 15293490 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training and vestibular rehabilitation in group sessions twice a week for six weeks
Number of subjects: 42
Study 15293490 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study 11430325 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (0.1 mg/kg body weight)
Number of subjects: 1202
Study 11430325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1202